In focus
Latest feed
Goyal urges Indian pharma to move beyond generics, focus on R&D at Bharat Health Expo 2026
Aurobindo’s CuraTeQ Secures Brazil GMP Nod, Paving Way for Biosimilars Expansion
The Humira Enigma: How a Patent Fortress Redefined Pharma Monopolies
The Future of US Pharma: Dr. Reddy's CEO Predicts Biosimilars to Eclipse Generics by Early 2030s
